As referred, Bozaoglu et al. [10] did not find significant differences between lean, overweight and obese Mexican-American patients with T2DM; nonetheless, in normal glucose-tolerant subjects, plasma chemerin levels were significantly associated with metabolic-syndrome-related parameters, including BMI, fasting serum insulin, triglycerides, and HDLc. This evidence concerns the gene INS and metabolic syndrome.